In the BioHarmony Drug Report Database
Padeliporfin
Tookad (padeliporfin) is a small molecule pharmaceutical. Padeliporfin was first approved as Tookad on 2017-11-10. It has been approved in Europe to treat prostatic neoplasms.
Trade Name
|
Tookad |
|---|---|
Common Name
|
padeliporfin |
ChEMBL ID
|
CHEMBL4594284 |
Indication
|
prostatic neoplasms |
Drug Class
|
Benzoporphyrin derivatives |
Image (chem structure or protein)
